Ocuphire Pharma, Inc. (OCUP)

$1.46 9.40% $0.12 Healthcare

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.

$38.12M

Ms. Mina Patel Sooch M.B.A., MBA

8.00

Farmington Hills, MI

Nov 10, 2005

-2.69

$-0.54

9.86

10.68

-85.75%

-2.40

-0.20

0.83

2.09

10.68

-31.46%

-30.19%

Similar stocks (13)

EyePoint Pharmaceuticals, Inc.

EYPT

$9.18 3.03%
Downtrend

Rigel Pharmaceuticals, Inc.

RIGL

$13.69 0.44%
Neutral

Kodiak Sciences Inc.

KOD

$2.58 -3.01%
Downtrend

Checkpoint Therapeutics, Inc.

CKPT

$2.43 -1.22%
Uptrend

Protalix BioTherapeutics, Inc.

PLX

$1.15 5.50%
Downtrend

SELLAS Life Sciences Group, Inc.

SLS

$1.22 0.00%
Uptrend

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$1.31 -5.07%
Downtrend

Fortress Biotech, Inc.

FBIOP

$5.60 -1.84%
Downtrend

Fortress Biotech, Inc.

FBIO

$1.84 -4.17%
Downtrend

Eyenovia, Inc.

EYEN

$0.50 0.10%
Downtrend

Cognition Therapeutics, Inc.

CGTX

$0.61 1.72%
Downtrend

Mustang Bio, Inc.

MBIO

$0.22 -12.17%
Downtrend

TransCode Therapeutics, Inc.

RNAZ

$0.38 8.00%
Downtrend

ETF Exposure (8)

iShares Micro-Cap ETF

IWC

0.00828%

$126.54 2.19%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend